[PMBI/DRUG/LTD.-228/2026] open

Bureau of Pharma PSUs of India (BPPI)

Ref: PMBI/DRUG/LTD.-228/2026 · ID: 2026_BPPI_912900_1

Value: ₹50,00,000

Category Drugs and Pharmaceutical Products

AI summary

This tender provides details about the project including scope of work, estimated value, deadlines, and eligibility requirements.

Overview

The Bureau of Pharma PSUs of India (BPPI) has issued a limited e-tender for the supply of Drug Code-217 (Ranitidine Tablets IP 150 mg). The tender is identified as [PMBI/DRUG/LTD.-228/2026] and is open for bids from 12-Jun-2026 until 19-Jun-2026. This procurement is categorized under 'Goods' and follows an item rate contract format.

Scope / Work

The primary objective of this tender is to procure Ranitidine Tablets IP 150 mg for BPPI. The total tender value is ₹5,000,000, and the successful bidder will be required to complete the work within 30 days from the date of contract award. Bidders must ensure compliance with the technical specifications and requirements outlined in the tender documents.

Fees & EMD

There is no tender fee associated with this tender. However, bidders are required to submit an Earnest Money Deposit (EMD) of ₹100,000, which is fixed and can be exempted under certain conditions. The EMD must be payable to the Office of PMBI in Delhi. Payment can be made through various offline modes, including Demand Draft, NEFT, RTGS, Bankers Cheque, and Bank Guarantee.

Key dates

  • Published Date: 12-Jun-2026 06:05 PM
  • Bid Submission Start Date: 13-Jun-2026 12:00 PM
  • Bid Submission End Date: 19-Jun-2026 05:00 PM
  • Bid Opening Date: 24-Jun-2026 04:30 PM
  • Document Download Start Date: 12-Jun-2026 06:05 PM
  • Document Download End Date: 19-Jun-2026 05:00 PM
  • Clarification Period: 12-Jun-2026 06:05 PM to 16-Jun-2026 05:00 PM

Bidders are encouraged to download the tender documents promptly and prepare their bids in accordance with the specified timelines to ensure compliance and competitiveness.

AI insights

Risk factors

  • EMD size of ₹100,000
  • tight bid submission timeline
  • bid validity of 60 days
  • no pre-bid meeting

Financials

Tender value ₹50,00,000
EMD amount ₹1,00,000 — payable to Office of PMBI at Delhi
Tender fee ₹0.00 — payable to Nil at Nil

Payment mode Offline

Timeline

Publish date 12 Jun 2026
Bid end 19 Jun 2026
Opening date 24 Jun 2026

Critical dates

From the portal detail page (all dates captured when available).

Bid Opening Date 24-Jun-2026 04:30 PM
Bid Submission End Date 19-Jun-2026 05:00 PM
Bid Submission Start Date 13-Jun-2026 12:00 PM
Clarification End Date 16-Jun-2026 05:00 PM
Clarification Start Date 12-Jun-2026 06:05 PM
Document Download / Sale End Date 19-Jun-2026 05:00 PM
Document Download / Sale Start Date 12-Jun-2026 06:05 PM
Published Date 12-Jun-2026 06:05 PM

Tender Documents

Tender documents will appear here once available.

Work details

Location, category, and schedule for this procurement.

Location As per tender document
Category Drugs and Pharmaceutical Products
Period of work 30 days
Bid validity 60 days

Tender basics

Tender type Limited
Form of contract Item Rate
Tender category Goods
No. of covers 2
Organisation chain Bureau of Pharma PSUs of India (BPPI)||Head Office(Gurgaon) - BPPI
Source portal eprocure.gov.in

Covers (bid packets)

What to submit in each cover, as listed on the tender portal.

Cover no. Cover type Description Document type
1 Fee/PreQual/Technical NIT to tender document for the supply of Drug Code-217 (Ranitidine Tablets IP 150 mg) to PMBI .pdf
Tender Document for the supply of Drug Code-217 (Ranitidine Tablets IP 150 mg) to PMBI. .pdf
Annexures/documents to tender document for the supply of Drug Code-217 to PMBI .pdf
2 Finance BOQ to tender document for the supply of Drug Code-217 (Ranitidine Tablets IP 150 mg) to PMBI .xls

Authority details

Inviting authority As per tender document
Address As per tender document
Payment instruments Offline (Demand Draft) , Offline (R-T-G-S) , Offline (NEFT) , Offline (Bankers Cheque) , Offline (Bank Guarantee)

Browse by tags

Jump to other tenders using these keywords.